Literature DB >> 27035742

Role of N-acetylgalactosaminyltransferase 6 in early tumorigenesis and formation of metastasis.

Friederike Liesche1, Alexandra C Kölbl1, Matthias Ilmer2, Stefan Hutter1, Udo Jeschke1, Ulrich Andergassen1.   

Abstract

Glycosylation is one of the most important posttranslational modifications of proteins and lipids that contributes to the structural diversity of cellular molecules. Enzymes of the glycosyltransferase class are responsible for altering glycosylation patterns by adding carbohydrate chains to the respective acceptor molecules. It is well known that glycosylation is commonly altered in cancerous tissue. Therefore, the present study aimed to determine the incidence of N‑acetylgalactosaminyltransferase 6 (GALNT6), a prominent member of the glycosyltransferase class, in breast cancer tissue of different developmental stages by immunohistochemistry. Although no correlation was identified between tumour characteristics and GALNT6 staining intensity, to the best of our knowledge, this is the first study to demonstrate that tissue from carcinoma in situ‑tumours and metastases were more heavily stained than late‑stage breast cancers. This may indicate an important role of glycosylation aberration in escaping the immune system at early phases of tumour development. The present study also hypothesised that nascent or early metastasizing tumours are normally recognized by the immune system of the patient, but glycosylation pattern changes may facilitate tumor escape from immune recognition. In follow‑up studies, our group will aim to confirm and consolidate these results in a larger patient cohort that may give greater insight into breast cancer characterization as well as tumour treatment.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27035742     DOI: 10.3892/mmr.2016.5044

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  7 in total

1.  De novo expression of human polypeptide N-acetylgalactosaminyltransferase 6 (GalNAc-T6) in colon adenocarcinoma inhibits the differentiation of colonic epithelium.

Authors:  Kirstine Lavrsen; Sally Dabelsteen; Sergey Y Vakhrushev; Asha M R Levann; Amalie Dahl Haue; August Dylander; Ulla Mandel; Lars Hansen; Morten Frödin; Eric P Bennett; Hans H Wandall
Journal:  J Biol Chem       Date:  2017-11-29       Impact factor: 5.157

2.  Mucin-Type O-GalNAc Glycosylation in Health and Disease.

Authors:  Ieva Bagdonaite; Emil M H Pallesen; Mathias I Nielsen; Eric P Bennett; Hans H Wandall
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 3.650

3.  Epigenome-wide association study and network analysis for IgA Nephropathy from CD19+ B-cell in Chinese Population.

Authors:  Yifei Lin; Peiran Yin; Zhaozhong Zhu; Yuan Peng; Ming Li; Jun Li; Liming Liang; Xueqing Yu
Journal:  Epigenetics       Date:  2021-01-07       Impact factor: 4.528

4.  Polypeptide N-acetylgalactosaminyltransferase-6 expression in gastric cancer.

Authors:  Yan Guo; Jingjing Shi; Jun Zhang; Haixin Li; Ben Liu; Hua Guo
Journal:  Onco Targets Ther       Date:  2017-07-07       Impact factor: 4.147

5.  Adipose Tissue Epigenetic Profile in Obesity-Related Dysglycemia - A Systematic Review.

Authors:  Sara Andrade; Tiago Morais; Ionel Sandovici; Alexandre L Seabra; Miguel Constância; Mariana P Monteiro
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-29       Impact factor: 5.555

6.  GALNT6 Promotes Tumorigenicity and Metastasis of Breast Cancer Cell via β-catenin/MUC1-C Signaling Pathway.

Authors:  Yingge Mao; Yuqi Zhang; Sairong Fan; Lvao Chen; Lili Tang; Xiaoming Chen; Jianxin Lyu
Journal:  Int J Biol Sci       Date:  2019-01-01       Impact factor: 6.580

Review 7.  MUC1 is an oncoprotein with a significant role in apoptosis (Review).

Authors:  Katarzyna Supruniuk; Iwona Radziejewska
Journal:  Int J Oncol       Date:  2021-07-19       Impact factor: 5.650

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.